Condition

GIST and CML (2)

Overall Status

Active, not recruiting (2)

Sign in for free

Phase

phase 4 (2)

Sponsor

Novartis Pharmaceuticals (2)

Collaborator

Intervention

imatinib mesylate (1)

nilotinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

gist and cml

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

GIST and CML Trial in Worldwide (AMN107)

Active, not recruiting

GIST and CML

Nilotinib

Albany, New York
+32 more

Oct 4, 2022

GIST and CML Trial in Worldwide (imatinib mesylate)

Active, not recruiting

GIST and CML

imatinib mesylate

Los Angeles, California
+28 more

Apr 25, 2022